Humacyte HUMA
NASDAQ HUMA
$0.41 0.00 (-0.17%)
As of: Oct 22, 2026 · 12:35 PM EDT

Humacyte (HUMA) FCF Margin (2020 - 2026)

Updated

Humacyte's FCF Margin was -5467.98% in Q2 2026, up 3495.81 percentage points from -8963.79% a year earlier but down 361.11 percentage points from the prior quarter.

Analysis

Humacyte (HUMA) FCF Margin (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Humacyte's FCF Margin was -4601.37% through Jun 30, 2026, up 8392.64 percentage points year-over-year; for FY2025, it was -5197.55%.

  • Quarterly FCF Margin has moved between -12697.93% (Q3 2021) and -3181.01% (Q3 2025) over five years.
  • Per Business Quant data, HUMA's FCF Margin in the three quarters before Q2 2026 was -5106.87% (Q1 2026), -5602.36% (Q4 2025) and -3181.01% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,170.90 Bn 1,139.49 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 643.26 Bn 561.78 Bn 17.26 Bn 28.82%
3 AbbVie 501.85 Bn 474.96 Bn 12.70 Bn 18.33%
4 Merck 370.72 Bn 325.10 Bn 12.21 Bn 26.96%
5 Novartis Ag 302.56 Bn 266.55 Bn 11.24 Bn 38.60%
6 Astrazeneca 268.35 Bn 242.04 Bn 12.86 Bn 6.55%
7 Amgen 242.39 Bn 197.79 Bn 7.24 Bn 34.70%
8 Gilead Sciences 193.22 Bn 167.42 Bn 6.22 Bn 44.00%
9 Pfizer 172.25 Bn 118.90 Bn 10.94 Bn 2.01%
10 Humacyte 96.13 Mn -102.31 Mn -825,000.00 -5,467.98%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5,467.98%
Mar 31, 2026 -5,106.87%
Dec 31, 2025 -5,602.36%
Sep 30, 2025 -3,181.01%
Jun 30, 2025 -8,963.79%
Mar 31, 2025 -5,576.21%
Sep 30, 2021 -12,697.93%
Sep 30, 2020 -1.97%
API Access

Humacyte FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=HUMA&period=max&api_key=YOUR_API_KEY